Concentration tests 2018
| Components | Unit | Round 2018.1 | Round 2018.2 | Round 2018.3 | Round 2018.4 |
|---|---|---|---|---|---|
| Antiretrovirals I | |||||
| Atazanavir | mg/l | ||||
| Darunavir | mg/l | ||||
| Dolutegravir | mg/l | ||||
| Elvitegrar | mg/l | ||||
| Lopinavir | mg/l | ||||
| Rilpivirine | mg/l | ||||
| Ritonavir | mg/l | ||||
| Saquinavir | mg/l | ||||
| Antiretrovirals II | |||||
| Amprenavir | mg/l | ||||
| Efavirenz | mg/l | ||||
| Etravirine | mg/l | ||||
| Nevirapine | mg/l | ||||
| Raltegravir | mg/l | ||||
| Tipranavir | mg/l |
Concentration tests 2017
| Components | Unit | Round 2017.1 | Round 2017.2 | Round 2017.3 | Round 2017.4 |
|---|---|---|---|---|---|
| Antiretrovirals I | |||||
| Atazanavir | mg/l | 1,91 | 0,459 | 4,77 | 0,306 |
| Darunavir | mg/l | 3,00 | 2,11 | 2,40 | 0,843 |
| Dolutegravir | mg/l | 0,0984 | 0,988 | 2,95 | 1,48 |
| Elvitegrar | mg/l | 0,121 | 1,51 | 0,754 | 1,01 |
| Lopinavir | mg/l | 1,05 | 7,56 | 2,64 | 3,78 |
| Rilpivirine | mg/l | — | — | 0,156 | 0,0313 |
| Ritonavir | mg/l | 0,388 | 0,975 | 1,94 | 2,44 |
| Saquinavir | mg/l | 2,91 | 0,0935 | 0,466 | 1,17 |
| Antiretrovirals II | |||||
| Amprenavir | mg/l | 0,398 | 3,92 | 0,998 | 3,00 |
| Efavirenz | mg/l | 0,787 | 4,65 | 1,18 | 3,95 |
| Etravirine | mg/l | 0,783 | 0,385 | 0,147 | 0,246 |
| Nevirapine | mg/l | 7,46 | 2,20 | 1,87 | 5,62 |
| Raltegravir | mg/l | 1,98 | 0,623 | 1,19 | 0,0596 |
| Tipranavir | mg/l | 19,50 | 19,18 | 14,65 | 39,17 |
Concentration tests 2016
| Components | Unit | Round 2016.1 | Round 2016.2 | Round 2016.3 | Round 2016.4 |
|---|---|---|---|---|---|
| Antiretrovirals I | |||||
| Atazanavir | mg/l | 0,218 | 1,51 | 0,903 | 3,01 |
| Darunavir | mg/l | 0,352 | 6,58 | 0 | 3,28 |
| Lopinavir | mg/l | 10,11 | 0,968 | 2,41 | 0,482 |
| Rilpivirine | mg/l | 0,0584 | 0,182 | 0,363 | 0,0348 |
| Ritonavir | mg/l | 0,427 | 2,67 | 6,64 | 0,848 |
| Saquinavir | mg/l | 0,0964 | 2,40 | 0,240 | 7,17 |
| Antiretrovirals II | |||||
| Amprenavir | mg/l | 0,241 | 0,239 | 0,400 | 4,82 |
| Efavirenz | mg/l | 0,867 | 5,37 | 6,47 | 0,433 |
| Etravirine | mg/l | 0,165 | 0,082 | 0,247 | 0,826 |
| Nevirapine | mg/l | 7,06 | 1,64 | 4,69 | 0,494 |
| Raltegravir | mg/l | 0 | 0,895 | 0 | 1,50 |
| Tipranavir | mg/l | 16,03 | 54,91 | 27,92 | 10,01 |
Concentration tests 2015
| Components | Unit | Round 2015.1 | Round 2015.2 | Round 2015.3 | Round 2015.4 |
|---|---|---|---|---|---|
| Antiretrovirals I | |||||
| Atazanavir | mg/l | 1,75 | 0,215 | 0,426 | 0,430 |
| Darunavir | mg/l | 4,47 | 0,858 | 0,530 | 1,07 |
| Lopinavir | mg/l | 0,529 | 12,09 | 7,96 | 1,09 |
| Rilpivirine | mg/l | 0,441 | 0,0408 | 1,05 | 0,109 |
| Ritonavir | mg/l | 0,977 | 5,02 | 1,98 | 0,752 |
| Saquinavir | mg/l | 0,0932 | 2,40 | 4,73 | 0,191 |
| Antiretrovirals II | |||||
| Amprenavir | mg/l | 5,65 | 0,793 | 0,221 | 2,83 |
| Efavirenz | mg/l | 4,58 | 0,661 | 1,32 | 1,32 |
| Etravirine | mg/l | 0,127 | 0,910 | 0,338 | 0,0848 |
| Nevirapine | mg/l | 15,72 | 1,70 | 3,14 | 1,13 |
| Raltegravir | mg/l | 0,0144 | 7,53 | 0,480 | 4,52 |
| Tipranavir | mg/l | 27,66 | 13,87 | 58,77 | 69 |
Concentration control (matrix: liquid human serum)
| Components | Weighed-in value | ||||
|---|---|---|---|---|---|
| Unit | 2017 | 2016 | 2015 | 2014 | |
| Antiretrovirals I | |||||
| Atazanavir | mg/l | 0,985 | 0,994 | 0,982 | 0,953 |
| Darunavir | mg/l | 4,96 | 4,51 | 5,03 | 4,81 |
| Dolutegravir | mg/l | 1,53 | – | – | – |
| Elvitegravir | mg/l | 1,04 | – | – | – |
| Lopinavir | mg/l | 7,01 | 6,91 | 6,62 | 7,09 |
| Nelfinavir | mg/l | – | – | – | 2,04 |
| Rilpivirine | mg/l | 0,302 | 0,299 | 0,298 | – |
| Ritonavir | mg/l | 5,02 | 4,93 | 4,95 | 5,05 |
| Saquinavir | mg/l | 1,50 | 1,48 | 1,57 | 1,48 |
| Antiretrovirals II | |||||
| Amprenavir | mg/l | 2,06 | 1,97 | 1,93 | 2,01 |
| Efavirenz | mg/l | 2,55 | 2,66 | 2,50 | 2,53 |
| Etravirine | mg/l | 1,02 | 1,02 | 1,03 | 0,977 |
| Nevirapine | mg/l | 3,87 | 3,85 | 4,02 | 4,00 |
| Raltegravir | mg/l | 2,05 | 1,97 | 2,05 | 1,94 |
| Tipranavir | mg/l | 15,16 | 14,76 | 15,72 | 14,81 |